News, Articles & Resources
Cancer Research and Cancer Support Articles
Learn about the importance of sleep hygiene and healthy sleep practices in promoting emotional wellbeing and coping skills in this edition of the FCS Behavioral Health Newsletter.
Richard McDonough, MD has been appointed as FCS Director of Patient Advocacy
Bradley Monk, MD will join Florida Cancer Specialists & Research Institute as Medical Director of Late-Phase Research effective in January 2024.
New technologies are helping to target tumors more precisely, reduce side effects and enhance patient comfort.
Research conducted by FCS confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for small cell lung cancer.
Hematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and Clearwater
PQI in Action for medically integrated teams on blood cancers and disorders co-authored by FCS clinicians
Tarek Eldawy, MD, medical oncologist and hematologist, joins Florida Cancer Specialists & Research Institute in Central Florida
FCS Top News Updates
April 28, 2026
FCS Leaders Spotlight Innovation and Collaboration at COA 2026 to Advance Community Oncology Care
April 24, 2026
FCS Advances Oncology Care Through Expert Collaboration and Innovative Exchange at Exclusive Event
April 15, 2026
FCS Highlights Leadership in Advancing Medically Integrated Oncology Care
April 13, 2026
FCS Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian Cancer
Practicing Healthy Sleep Practices and Sleep Hygiene to Promote WellbeingLearn about the importance of sleep hygiene and healthy sleep practices in promoting emotional wellbeing and coping skills in this edition of the FCS Behavioral Health Newsletter.
Richard McDonough, MD has been appointed as FCS Director of Patient AdvocacyRichard McDonough, MD has been appointed as FCS Director of Patient Advocacy
Bradley Monk, MD will join FCS as Medical Director of Late-Phase Research effective in January 2024Bradley Monk, MD will join Florida Cancer Specialists & Research Institute as Medical Director of Late-Phase Research effective in January 2024.
New Technologies Enhance Safety and Comfort for Patients Receiving RadiationNew technologies are helping to target tumors more precisely, reduce side effects and enhance patient comfort.
New Treatment Minimizes Side Effects of Chemotherapy for Lung Cancer PatientsResearch conducted by FCS confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for small cell lung cancer.
Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and ClearwaterHematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and Clearwater
FCS Clinicians Co-author Positive Quality Intervention for Blood Cancers and DisordersPQI in Action for medically integrated teams on blood cancers and disorders co-authored by FCS clinicians
Tarek Eldawy, MD joins FCSTarek Eldawy, MD, medical oncologist and hematologist, joins Florida Cancer Specialists & Research Institute in Central Florida